- Home
- SLNO vs EVCM Comparison
SLNO vs EVCM Comparison
Compare SLNO & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- EVCM
- Stock Information
- Founded
- SLNO 1999
- EVCM 2006
- Country
- SLNO United States
- EVCM United States
- Employees
- SLNO N/A
- EVCM N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EVCM EDP Services
- Sector
- SLNO Health Care
- EVCM Technology
- Exchange
- SLNO Nasdaq
- EVCM Nasdaq
- Market Cap
- SLNO 1.9B
- EVCM 1.9B
- IPO Year
- SLNO 2014
- EVCM 2021
- Fundamental
- Price
- SLNO $53.89
- EVCM $10.50
- Analyst Decision
- SLNO Strong Buy
- EVCM Buy
- Analyst Count
- SLNO 7
- EVCM 11
- Target Price
- SLNO $68.71
- EVCM $11.45
- AVG Volume (30 Days)
- SLNO 803.1K
- EVCM 77.7K
- Earning Date
- SLNO 11-05-2024
- EVCM 11-04-2024
- Dividend Yield
- SLNO N/A
- EVCM N/A
- EPS Growth
- SLNO N/A
- EVCM N/A
- EPS
- SLNO N/A
- EVCM N/A
- Revenue
- SLNO N/A
- EVCM $691,687,000.00
- Revenue This Year
- SLNO N/A
- EVCM $4.47
- Revenue Next Year
- SLNO N/A
- EVCM $5.08
- P/E Ratio
- SLNO N/A
- EVCM N/A
- Revenue Growth
- SLNO N/A
- EVCM 6.23
- 52 Week Low
- SLNO $21.30
- EVCM $6.22
- 52 Week High
- SLNO $56.81
- EVCM $12.35
- Technical
- Relative Strength Index (RSI)
- SLNO 57.97
- EVCM 52.49
- Support Level
- SLNO $53.02
- EVCM $9.98
- Resistance Level
- SLNO $54.86
- EVCM $10.90
- Average True Range (ATR)
- SLNO 2.13
- EVCM 0.20
- MACD
- SLNO 0.23
- EVCM 0.05
- Stochastic Oscillator
- SLNO 68.82
- EVCM 57.89
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..